BioCryst Pharmaceuticals, Inc. (BCRX)
6.67
+0.01
(+0.15%)
USD |
NASDAQ |
Jan 20, 16:00
6.67
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals EPS Diluted (Quarterly): 0.0587 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Astria Therapeutics, Inc. | -0.5455 |
| Hologic, Inc. | 0.8298 |
| Bruker Corp. | -0.4111 |
| Viatris, Inc. | -0.1101 |
| KalVista Pharmaceuticals, Inc. | -0.9183 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.90M |
| Revenue (Quarterly) | 159.40M |
| Total Expenses (Quarterly) | 146.50M |
| Enterprise Value | 1.875B |
| Gross Profit Margin (Quarterly) | 98.42% |
| Profit Margin (Quarterly) | 8.09% |
| Earnings Yield | -0.71% |
| Operating Earnings Yield | 5.29% |
| Normalized Earnings Yield | -0.3793 |